Promising Growth Stocks To Add to Your Watchlist - June 20th

Circle Internet Group, Blueprint Medicines, Novo Nordisk A/S, SpringWorks Therapeutics, and BlackRock are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Circle Internet Group (CRCL)

Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Shares of Circle Internet Group stock traded up $42.32 during mid-day trading on Friday, hitting $241.91. 62,296,432 shares of the stock were exchanged, compared to its average volume of 40,258,852. The stock has a market cap of $53.83 billion and a P/E ratio of -19,117.28. Circle Internet Group has a 12 month low of $64.00 and a 12 month high of $244.20.

Read Our Latest Research Report on CRCL

Blueprint Medicines (BPMC)

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders.

Shares of NASDAQ:BPMC traded up $0.03 during mid-day trading on Friday, reaching $128.15. The company had a trading volume of 3,011,578 shares, compared to its average volume of 1,248,052. The company's 50-day moving average price is $103.81 and its 200-day moving average price is $97.91. The company has a current ratio of 2.80, a quick ratio of 2.75 and a debt-to-equity ratio of 1.01. Blueprint Medicines has a one year low of $73.04 and a one year high of $128.38. The firm has a market cap of $8.28 billion, a price-to-earnings ratio of -51.89 and a beta of 0.84.

Read Our Latest Research Report on BPMC

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of Novo Nordisk A/S stock traded down $0.16 during trading on Friday, hitting $73.85. The stock had a trading volume of 4,921,361 shares, compared to its average volume of 7,070,774. The company has a current ratio of 0.74, a quick ratio of 0.56 and a debt-to-equity ratio of 0.70. The business's 50-day moving average is $68.23 and its 200 day moving average is $78.93. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15.

Read Our Latest Research Report on NVO

SpringWorks Therapeutics (SWTX)

SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.

Shares of SWTX traded up $0.21 during midday trading on Friday, reaching $46.99. The stock had a trading volume of 7,546,380 shares, compared to its average volume of 2,458,156. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of -13.78 and a beta of 0.70. SpringWorks Therapeutics has a 12-month low of $28.21 and a 12-month high of $62.00. The company's 50-day moving average is $44.92 and its 200 day moving average is $43.94.

Read Our Latest Research Report on SWTX

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

BlackRock stock traded down $1.64 during trading hours on Friday, reaching $977.88. The company had a trading volume of 249,047 shares, compared to its average volume of 689,122. The company has a debt-to-equity ratio of 0.38, a current ratio of 4.34 and a quick ratio of 4.34. BlackRock has a 12-month low of $773.74 and a 12-month high of $1,084.22. The firm has a market cap of $151.50 billion, a price-to-earnings ratio of 23.77, a P/E/G ratio of 2.97 and a beta of 1.41. The company has a 50-day moving average price of $946.64 and a 200 day moving average price of $970.82.

Read Our Latest Research Report on BLK

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.